An interventional study of Discharge Assistance and Supports at Home (DASH) in Stroke, Stroke Rehabilitation and Transitional Care, sponsored by Bruyère Health Research Institute.. Not yet recruiting at 6 sites in Canada. Per ClinicalTrials.gov, last updated 2026-05-18.
Sponsored by Bruyère Health Research Institute. · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to learn if a home visit by a trained volunteer can improve stroke recovery after a stroke survivor is discharged home from the hospital. The main questions it aims to answer are:
Researchers will compare between a group who will receive the volunteer support and a group who will not to see if the additional support can improve stroke recovery.
Participants will:
Acute stroke often leads to adult disability in Canada, and about 108,707 Canadians experience a stroke each year. While most people survive stroke (80 percent) and return home, some survivors are left with ongoing challenges that require them to seek help in the community. These challenges can lead to stress for the individual and their caregiver. Research on volunteer-supported home-to-hospital programs has shown positive outcomes. However, despite the growing evidence that supports volunteer engagement in care transitions, we have yet to determine the impact of a complex psychosocial volunteer-delivered care transition intervention for stroke survivors. This study will assess whether a volunteer-delivered transitional care intervention, designed by Bruyère Health Research Institute in partnership with March of Dimes Canada (MODC), for adults discharged home from a stroke rehabilitation unit following an acute stroke can improve coping compared to usual care. MODC will implement the volunteer-support transition program across two Ontario regions for stroke rehabilitation sites. Those allocated to the intervention group will receive an initial visit from the Volunteer Coordinator and then weekly one-on-one visits by a trained volunteer for eight weeks. The volunteer may assist the study participant with instrumental daily living activities and psychosocial and informational support. Those not receiving the intervention will receive educational material at 4- and 8-week time points in addition to their usual care. All study participants will complete validated patient-reported outcome measures at 3- and 6-months post-hospital discharge.
8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.
This study's planned enrollment of 840 is above the median of 49 across 6,024 interventional studies indexed under Stroke.
Browse Stroke studies →Bruyère Health Research Institute. is the lead sponsor of 9 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive the DASH intervention + Usual Care + Educational Resources
Behavioral: Discharge Assistance and Supports at Home (DASH)
Participants will receive the Usual Care + Educational Resources
One-on-one weekly visits in the stroke survivor participants' residence by a trained volunteer for approximately 8 weeks (about 2 months). Volunteer support could span three types: i) instrumental activities of daily living assistance (e.g., assistance with meal preparation, light house duties, and transportation), ii) psychosocial support (e.g., befriending visits), and iii) informational supports (signposting to other community services).
Coping at Time 1 as assessed by Post-Discharge Coping Difficulty Scale (PDCDS)
Coping will be assessed using the Post-Discharge Coping Difficulty Scale (PDCDS), a 10-item patient-reported outcome measure evaluating perceived difficulty coping following hospital discharge. Each item is scored on a scale from 0 to 10. Item scores are summed to yield a total score ranging from 0 to 100, with higher scores indicating greater difficulty coping.
Time frame: Measured at 3 months post-hospital discharge
Change in coping as assessed by Post-Discharge Coping Difficulty Scale (PDCDS)
Coping will be assessed using the Post-Discharge Coping Difficulty Scale (PDCDS), a 10-item patient-reported measure. Each item is scored from 0 to 10, with total scores ranging from 0 to 100. Change in total score will be calculated between time points. Higher scores indicate greater difficulty coping.
Time frame: Measured at 3 months and 6 months post-hospital discharge
Change in quality of life as assessed by Stroke-Specific Quality of Life (SS-QOL)
Quality of life will be assessed using the Stroke-Specific Quality of Life (SS-QOL) scale, a 49-item patient-reported measure evaluating multiple domains of health-related quality of life in stroke survivors. Each item is scored on a 5-point Likert scale (1 to 5). Domain scores are calculated as the average of items within each domain, and the overall score is calculated as the average of all domain scores or as the sum of all 49 items (ranging 49 to 245). Higher scores indicate better quality of life.
Time frame: Measured at 3 months and 6 months post-hospital discharge
Change in symptoms of depression as assessed by Patient Health Questionnaire-9 (PHQ-9)
Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9), a 9-item patient-reported measure. Each item is scored from 0 to 3, resulting in a total score ranging from 0 to 27, with higher scores indicating greater severity of depressive symptoms.
Time frame: Measured at 3 months and 6 months post-hospital discharge
Change in social isolation and loneliness indicators as assessed by UCLA Loneliness Scale (Version 3)
Social isolation and loneliness will be assessed using the UCLA Loneliness Scale (Version 3), a 20-item patient-reported measure evaluating subjective feelings of loneliness and social isolation. Each item is scored on a 4-point scale. Total scores range from 20 to 80, with higher scores indicating greater loneliness.
Time frame: Measured at 3 months and 6 months post-hospital discharge
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Undecided
Start is estimated for Jun 2026; primary completion for Jan 2028, 19 months later.
Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 19 months is below that.
Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bruyère Health Research Institute.